Key result
Genetic manipulation of periostin fails to stimulate cardiomyocyte DNA synthesis, mitosis, or cytokinesis.
Why the study?
Does genetic manipulation of periostin expression improve cardiac repair and cardiomyocyte regeneration in mice following myocardial infarction?
Does genetic manipulation of periostin expression improve cardiac repair and cardiomyocyte regeneration in mice following myocardial infarction?
Genetic manipulation of periostin does not stimulate cardiomyocyte cell cycle reentry or myocardial regeneration following injury, challenging previous hypotheses regarding its regenerative potential.
Answers are grounded in this paper and cite their sources.
Periostin manipulation does not promote cardiomyocyte proliferation or repair in mice; leaves open isoform- or context-specific regenerative roles pending further validation.
Following a pathological insult, the adult mammalian heart undergoes hypertrophic growth and remodeling of the extracellular matrix. Although a small subpopulation of cardiomyocytes can reenter the cell cycle following cardiac injury, the myocardium is largely thought to be incapable of significant regeneration. Periostin, an extracellular matrix protein, has recently been proposed to induce reentry of differentiated cardiomyocytes back into the cell cycle and promote meaningful repair following myocardial infarction. Here, we show that although periostin is induced in the heart following injury, it does not stimulate DNA synthesis, mitosis, or cytokinesis of cardiomyocytes in vitro or in vivo. Mice lacking the gene encoding periostin and mice with inducible overexpression of full-length periostin were analyzed at baseline and after myocardial infarction. There was no difference in heart size or a change in cardiomyocyte number in either periostin transgenic or gene-targeted mice at baseline. Quantification of proliferating myocytes in the periinfarct area showed no difference between periostin-overexpressing and -null mice compared with strain-matched controls. In support of these observations, neither overexpression of periostin in cell culture, via an adenoviral vector, nor stimulation with recombinant protein induced DNA synthesis, mitosis, or cytokinesis. Periostin is a regulator of cardiac remodeling and hypertrophy and may be a reasonable pharmacological target to mitigate heart failure, but manipulation of this protein appears to have no obvious effect on myocardial regeneration.
No takes yet. Share an insight, caveat, or question.
Lorts et al. (2008) studied Myocardial infarction. Genetic manipulation of periostin expression (knockout and overexpression) vs. Strain-matched controls was evaluated on Cardiomyocyte DNA synthesis, mitosis, cytokinesis, and cell cycle reentry. Genetic manipulation of periostin expression, either through gene targeting or overexpression, did not stimulate cardiomyocyte DNA synthesis, mitosis, or cytokinesis in vitro or in vivo.
Synapse has enriched 10 related papers. Consider them for comparative context: